These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 38387080)
61. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Mangiarini L; Sathasivam K; Mahal A; Mott R; Seller M; Bates GP Nat Genet; 1997 Feb; 15(2):197-200. PubMed ID: 9020849 [TBL] [Abstract][Full Text] [Related]
62. Somatic CAG expansion in Huntington's disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection. Roy JCL; Vitalo A; Andrew MA; Mota-Silva E; Kovalenko M; Burch Z; Nhu AM; Cohen PE; Grabczyk E; Wheeler VC; Mouro Pinto R Nucleic Acids Res; 2021 Apr; 49(7):3907-3918. PubMed ID: 33751106 [TBL] [Abstract][Full Text] [Related]
63. RNA toxicity induced by expanded CAG repeats in Huntington's disease. Martí E Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325 [TBL] [Abstract][Full Text] [Related]
64. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143 [TBL] [Abstract][Full Text] [Related]
65. Age-, tissue- and length-dependent bidirectional somatic CAG•CTG repeat instability in an allelic series of R6/2 Huntington disease mice. Larson E; Fyfe I; Morton AJ; Monckton DG Neurobiol Dis; 2015 Apr; 76():98-111. PubMed ID: 25662336 [TBL] [Abstract][Full Text] [Related]
66. Modification of Huntington's disease by short tandem repeats. Hong EP; Ramos EM; Aziz NA; Massey TH; McAllister B; Lobanov S; Jones L; Holmans P; Kwak S; Orth M; Ciosi M; Lomeikaite V; Monckton DG; Long JD; Lucente D; Wheeler VC; Gillis T; MacDonald ME; Sequeiros J; Gusella JF; Lee JM Brain Commun; 2024; 6(2):fcae016. PubMed ID: 38449714 [TBL] [Abstract][Full Text] [Related]
67. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease. Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131 [TBL] [Abstract][Full Text] [Related]
68. Huntington's Disease: Relationship Between Phenotype and Genotype. Sun YM; Zhang YB; Wu ZY Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514 [TBL] [Abstract][Full Text] [Related]
69. A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice. Suelves N; Kirkham-McCarthy L; Lahue RS; Ginés S Sci Rep; 2017 Jul; 7(1):6082. PubMed ID: 28729730 [TBL] [Abstract][Full Text] [Related]
70. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea]. Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360 [TBL] [Abstract][Full Text] [Related]
71. Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset. Vatsavayai SC; Dallérac GM; Milnerwood AJ; Cummings DM; Rezaie P; Murphy KP; Hirst MC Brain Res Bull; 2007 Apr; 72(2-3):98-102. PubMed ID: 17352932 [TBL] [Abstract][Full Text] [Related]
72. Alternative processing of human HTT mRNA with implications for Huntington's disease therapeutics. Fienko S; Landles C; Sathasivam K; McAteer SJ; Milton RE; Osborne GF; Smith EJ; Jones ST; Bondulich MK; Danby ECE; Phillips J; Taxy BA; Kordasiewicz HB; Bates GP Brain; 2022 Dec; 145(12):4409-4424. PubMed ID: 35793238 [TBL] [Abstract][Full Text] [Related]
73. Antagonistic roles of canonical and Alternative-RPA in disease-associated tandem CAG repeat instability. Gall-Duncan T; Luo J; Jurkovic CM; Fischer LA; Fujita K; Deshmukh AL; Harding RJ; Tran S; Mehkary M; Li V; Leib DE; Chen R; Tanaka H; Mason AG; Lévesque D; Khan M; Razzaghi M; Prasolava T; Lanni S; Sato N; Caron MC; Panigrahi GB; Wang P; Lau R; Castel AL; Masson JY; Tippett L; Turner C; Spies M; La Spada AR; Campos EI; Curtis MA; Boisvert FM; Faull RLM; Davidson BL; Nakamori M; Okazawa H; Wold MS; Pearson CE Cell; 2023 Oct; 186(22):4898-4919.e25. PubMed ID: 37827155 [TBL] [Abstract][Full Text] [Related]
75. Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease. Bao YF; Li XY; Dong Y; Wu ZY J Mol Med (Berl); 2023 Jul; 101(7):869-876. PubMed ID: 37231148 [TBL] [Abstract][Full Text] [Related]
76. HttQ111/+ Huntington's Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction. Kovalenko M; Milnerwood A; Giordano J; St Claire J; Guide JR; Stromberg M; Gillis T; Sapp E; DiFiglia M; MacDonald ME; Carroll JB; Lee JM; Tappan S; Raymond L; Wheeler VC J Huntingtons Dis; 2018; 7(1):17-33. PubMed ID: 29480209 [TBL] [Abstract][Full Text] [Related]
77. Genetics and neuropathology of Huntington's disease. Reiner A; Dragatsis I; Dietrich P Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094 [TBL] [Abstract][Full Text] [Related]
78. Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models. Wheeler VC; Dion V J Huntingtons Dis; 2021; 10(1):123-148. PubMed ID: 33579861 [TBL] [Abstract][Full Text] [Related]